Literature DB >> 6528183

Failure of sera from patients with scleroderma to exhibit cytotoxicity towards human umbilical vein endothelial cells.

G D Summers, J B Weiss, M I Jayson.   

Abstract

Human umbilical vein endothelial cells grew equally well in sera from scleroderma patients and in sera from rheumatic controls. Using two independent methods of assessing cell growth, no evidence of a previously described endothelial cell cytotoxic factor could be found in heat inactivated sera from 23 scleroderma patients. The system used was sensitive in detecting growth inhibition due to five batches of foetal calf serum and low concentrations of homocysteine and 2-mercaptoethanol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6528183     DOI: 10.1007/bf00541359

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  Pathogenesis of systemic sclerosis: a vascular hypothesis.

Authors:  P M Campbell; E C LeRoy
Journal:  Semin Arthritis Rheum       Date:  1975-05       Impact factor: 5.532

2.  Modulation of collagen synthesis by a growth factor and by the extracellular matrix: comparison of cellular response to two different stimuli.

Authors:  S C Tseng; N Savion; D Gospodarowicz; R Stern
Journal:  J Cell Biol       Date:  1983-09       Impact factor: 10.539

3.  Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.

Authors:  H R Maricq; E C LeRoy; W A D'Angelo; T A Medsger; G P Rodnan; G C Sharp; J F Wolfe
Journal:  Arthritis Rheum       Date:  1980-02

4.  Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred.

Authors:  W B Sheldon; D P Lurie; H R Maricq; M B Kahaleh; F A DeLustro; A Gibofsky; E C LeRoy
Journal:  Arthritis Rheum       Date:  1981-05

5.  Cytotoxic activity of sera from scleroderma and other connective tissue diseases. Lack of cellular and disease specificity.

Authors:  W R Shanahan; J H Korn
Journal:  Arthritis Rheum       Date:  1982-12

Review 6.  Vascular disease in progressive systemic sclerosis (scleroderma).

Authors:  W L Norton; J M Nardo
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

7.  Extracellular matrix and control of proliferation of vascular endothelial cells.

Authors:  D Gospodarowicz; C Ill
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

Review 8.  Systemic sclerosis--a microvascular disorder?

Authors:  M I Jayson
Journal:  J R Soc Med       Date:  1983-08       Impact factor: 18.000

9.  Human vascular endothelial cells in culture. Growth and DNA synthesis.

Authors:  M A Gimbrone; R S Cotran; J Folkman
Journal:  J Cell Biol       Date:  1974-03       Impact factor: 10.539

10.  Endothelial injury in scleroderma.

Authors:  M B Kahaleh; G K Sherer; E C LeRoy
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  3 in total

Review 1.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Cytotoxic effects of sera from patients with systemic scleroderma: comparison of three different in vitro methods.

Authors:  S Majewski; M Błaszczyk; S Jabłonska; L Rudnicka; M Waşik; A Skiendzielewska; B Makieła
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.

Authors:  J Rosenbaum; B E Pottinger; P Woo; C M Black; S Loizou; M A Byron; J D Pearson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.